$3.11 Billion is the total value of Tekla Capital Management LLC's 172 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 27.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRNA | Sell | Moderna, Inc. | $176,826,000 | +61.6% | 459,456 | -1.4% | 5.69% | +60.1% |
| AMGN | Buy | Amgen Inc. | $122,256,000 | +8.2% | 574,918 | +24.1% | 3.94% | +7.2% |
| UNH | Sell | Unitedhealth Group Inc. | $119,617,000 | -5.3% | 306,129 | -3.0% | 3.85% | -6.2% |
| GILD | Buy | Gilead Sciences, Inc. | $119,308,000 | +6.0% | 1,708,065 | +4.5% | 3.84% | +5.0% |
| HZNP | Sell | Horizon Therapeutics plcshares | $99,719,000 | +13.7% | 910,340 | -2.8% | 3.21% | +12.7% |
| REGN | Buy | Regeneron Pharmaceuticals, Inc. | $89,576,000 | +16.1% | 148,015 | +7.2% | 2.88% | +15.0% |
| TMO | Buy | Thermo Fisher Scientific Inc. | $83,480,000 | +18.1% | 146,116 | +4.3% | 2.69% | +17.0% |
| JNJ | Johnson & Johnson | $83,439,000 | -2.0% | 516,652 | 0.0% | 2.69% | -2.9% | |
| ILMN | Sell | Illumina, Inc. | $78,673,000 | -17.6% | 193,963 | -3.9% | 2.53% | -18.4% |
| ABT | Sell | Abbott Laboratories | $77,616,000 | -10.9% | 657,038 | -12.5% | 2.50% | -11.7% |
| MDT | Buy | Medtronic plcshares | $75,301,000 | +11.0% | 600,722 | +9.9% | 2.42% | +10.0% |
| BIIB | Buy | Biogen Inc. | $66,178,000 | -8.6% | 233,853 | +11.8% | 2.13% | -9.4% |
| LLY | Buy | Eli Lilly and Company | $63,639,000 | +8.1% | 275,432 | +7.4% | 2.05% | +7.1% |
| MRK | Buy | Merck & Co., Inc. | $61,313,000 | +45.5% | 816,305 | +50.7% | 1.97% | +44.2% |
| ABBV | Sell | AbbVie Inc. | $56,547,000 | -18.7% | 524,213 | -15.1% | 1.82% | -19.4% |
| VRTX | Sell | Vertex Pharmaceuticals Inc. | $49,528,000 | -37.9% | 273,046 | -30.9% | 1.60% | -38.4% |
| IDXX | Buy | IDEXX Laboratories, Inc. | $49,542,000 | +125.3% | 79,663 | +128.8% | 1.60% | +123.4% |
| AZN | Buy | AstraZeneca plcsponsored adr | $48,824,000 | +81.8% | 812,927 | +81.3% | 1.57% | +80.1% |
| GH | Buy | Guardant Health, Inc. | $48,502,000 | +146.1% | 387,984 | +144.4% | 1.56% | +143.7% |
| DHR | Sell | Danaher Corp. | $45,265,000 | +1.5% | 148,683 | -10.6% | 1.46% | +0.6% |
| CI | Buy | Cigna Corp. | $44,383,000 | -11.3% | 221,740 | +5.1% | 1.43% | -12.1% |
| SYK | Stryker Corp. | $39,690,000 | +1.5% | 150,500 | 0.0% | 1.28% | +0.6% | |
| SRPT | Buy | Sarepta Therapeutics, Inc. | $39,444,000 | +162.6% | 426,514 | +120.7% | 1.27% | +160.2% |
| New | Rallybio Corp. | $37,608,000 | – | 2,308,672 | +100.0% | 1.21% | – | |
| MCK | Buy | McKesson Corp. | $36,203,000 | +25.6% | 181,577 | +20.5% | 1.17% | +24.4% |
| BMY | Sell | Bristol-Myers Squibb Company | $36,226,000 | -17.4% | 612,236 | -6.7% | 1.17% | -18.1% |
| ALNY | Buy | Alnylam Pharmaceuticals, Inc. | $35,816,000 | +57.1% | 189,695 | +41.0% | 1.15% | +55.6% |
| SGEN | Sell | Seagen Inc. | $35,205,000 | +5.8% | 207,334 | -1.6% | 1.13% | +4.9% |
| ZBH | Zimmer Biomet Holdings, Inc. | $32,595,000 | -9.0% | 222,703 | 0.0% | 1.05% | -9.8% | |
| CRL | Buy | Charles River Laboratories International, Inc. | $32,388,000 | +60.1% | 78,484 | +43.5% | 1.04% | +58.8% |
| NVAX | Buy | Novavax, Inc. | $31,406,000 | +68.9% | 151,491 | +72.9% | 1.01% | +67.4% |
| ZTS | Buy | Zoetis Inc.class a | $27,684,000 | +162.8% | 142,597 | +152.3% | 0.89% | +160.5% |
| HCA | Sell | HCA Healthcare, Inc. | $27,175,000 | +5.4% | 111,961 | -10.2% | 0.88% | +4.4% |
| UTHR | Buy | United Therapeutics Corp.class b | $26,753,000 | +6.9% | 144,940 | +3.9% | 0.86% | +5.9% |
| LH | Buy | Laboratory Corporation of America Holdingssponsored adr | $26,640,000 | +37.2% | 94,656 | +34.5% | 0.86% | +36.0% |
| ICLR | Buy | Icon plcshares | $25,906,000 | +244.7% | 98,871 | +171.9% | 0.83% | +241.8% |
| DXCM | Sell | Dexcom, Inc. | $23,504,000 | -33.5% | 42,980 | -48.1% | 0.76% | -34.1% |
| BGNE | Buy | BeiGene, Ltd.sponsored adr | $23,149,000 | +46.7% | 63,772 | +38.7% | 0.74% | +45.2% |
| MOH | Buy | Molina Healthcare, Inc. | $22,688,000 | +40.9% | 83,625 | +31.5% | 0.73% | +39.8% |
| BNTX | Buy | BioNTech SEsponsored ads | $22,046,000 | +72.5% | 80,757 | +41.5% | 0.71% | +71.1% |
| EW | Sell | Edwards Lifesciences Corp. | $22,034,000 | -4.0% | 194,630 | -12.2% | 0.71% | -5.0% |
| EXAS | Buy | Exact Sciences Corp. | $21,503,000 | -13.4% | 225,282 | +12.8% | 0.69% | -14.3% |
| XRAY | Sell | DENTSPLY SIRONA Inc. | $21,335,000 | -11.8% | 367,521 | -3.9% | 0.69% | -12.6% |
| SYNH | Syneos Health, Inc.class a | $21,313,000 | -2.2% | 243,633 | 0.0% | 0.69% | -3.2% | |
| HUM | Sell | Humana Inc. | $20,677,000 | -19.7% | 53,135 | -8.6% | 0.67% | -20.3% |
| ISRG | Sell | Intuitive Surgical, Inc. | $19,885,000 | +1.5% | 20,002 | -6.1% | 0.64% | +0.6% |
| PFE | Pfizer Inc. | $19,371,000 | +9.8% | 450,379 | 0.0% | 0.62% | +8.9% | |
| CTLT | Buy | Catalent, Inc. | $19,151,000 | +121.3% | 143,913 | +79.8% | 0.62% | +119.6% |
| IQV | Buy | IQVIA Holdings Inc. | $18,359,000 | +33.5% | 76,644 | +35.0% | 0.59% | +32.2% |
| CRSP | CRISPR Therapeutics AGnamen akt | $18,170,000 | -30.9% | 162,337 | 0.0% | 0.58% | -31.5% | |
| XLV | Sell | Health Care Select Sector SPDR Fundsbi healthcare | $16,909,000 | -28.9% | 132,830 | -29.7% | 0.54% | -29.6% |
| WELL | Welltower Inc. | $16,734,000 | -0.8% | 203,083 | 0.0% | 0.54% | -1.6% | |
| New | Caribou Biosciences, Inc. | $15,621,000 | – | 699,377 | +100.0% | 0.50% | – | |
| JAZZ | Buy | Jazz Pharmaceuticals plcshares | $14,852,000 | +23.9% | 114,059 | +69.1% | 0.48% | +22.9% |
| MRTX | Mirati Therapeutics, Inc. | $14,822,000 | +9.5% | 83,784 | 0.0% | 0.48% | +8.4% | |
| VTR | Buy | Ventas, Inc. | $13,699,000 | +15.3% | 248,131 | +19.2% | 0.44% | +14.2% |
| ARWR | Buy | Arrowhead Pharmaceuticals, Inc. | $12,749,000 | +15.8% | 204,214 | +53.7% | 0.41% | +14.8% |
| RARE | Buy | Ultragenyx Pharmaceutical Inc. | $12,692,000 | -1.1% | 140,726 | +4.6% | 0.41% | -1.9% |
| BHVN | New | Biohaven Pharmaceutical Holding Company Ltd. | $12,613,000 | – | 90,799 | +100.0% | 0.41% | – |
| CVS | CVS Health Corp. | $12,513,000 | +1.7% | 147,453 | 0.0% | 0.40% | +0.8% | |
| KRTX | Karuna Therapeutics, Inc. | $12,289,000 | +7.3% | 100,458 | 0.0% | 0.40% | +6.5% | |
| ITCI | Buy | Intra-Cellular Therapies, Inc. | $12,094,000 | +46.1% | 324,401 | +60.0% | 0.39% | +44.6% |
| NBIX | Sell | Neurocrine Biosciences, Inc. | $11,951,000 | -42.3% | 124,609 | -41.5% | 0.38% | -42.8% |
| IMAB | I-Mabsponsored ads | $11,785,000 | -13.7% | 162,580 | 0.0% | 0.38% | -14.6% | |
| ARGX | Sell | argenx SEsponsored adr | $11,614,000 | -48.2% | 38,456 | -48.3% | 0.37% | -48.6% |
| ALKS | New | Alkermes plcshares | $11,529,000 | – | 373,824 | +100.0% | 0.37% | – |
| ADPT | Adaptive Biotechnologies Corp. | $11,479,000 | -16.8% | 337,722 | 0.0% | 0.37% | -17.4% | |
| DNLI | Buy | Denali Therapeutics Inc. | $11,221,000 | -4.7% | 222,420 | +48.2% | 0.36% | -5.7% |
| NVS | Novartis AGsponsored adr | $11,140,000 | -10.4% | 136,225 | 0.0% | 0.36% | -11.1% | |
| ASND | Sell | Ascendis Pharma A/Ssponsored adr | $10,806,000 | -46.5% | 67,794 | -55.9% | 0.35% | -47.0% |
| IONS | Ionis Pharmaceuticals, Inc. | $10,817,000 | -15.9% | 322,521 | 0.0% | 0.35% | -16.7% | |
| BDX | Becton, Dickinson and Company | $10,646,000 | +1.1% | 43,307 | 0.0% | 0.34% | +0.3% | |
| WAT | Sell | Waters Corp. | $10,169,000 | -39.1% | 28,461 | -41.1% | 0.33% | -39.8% |
| BMRN | BioMarin Pharmaceutical Inc. | $9,893,000 | -7.4% | 128,004 | 0.0% | 0.32% | -8.1% | |
| OMI | Buy | Owens & Minor, Inc. | $9,230,000 | -18.0% | 294,967 | +10.9% | 0.30% | -18.9% |
| NVO | Buy | Novo Nordisk A/Ssponsored adr | $9,188,000 | +126.6% | 95,703 | +97.7% | 0.30% | +124.2% |
| OHI | Omega Healthcare Investors, Inc. | $9,181,000 | -17.4% | 306,433 | 0.0% | 0.30% | -18.0% | |
| MTD | Sell | Mettler-Toledo International Inc. | $9,159,000 | -32.5% | 6,650 | -32.1% | 0.30% | -33.1% |
| DOC | Physicians Realty Trust | $8,735,000 | -4.6% | 495,733 | 0.0% | 0.28% | -5.7% | |
| GTHX | G1 Therapeutics, Inc. | $8,379,000 | -38.8% | 624,369 | 0.0% | 0.27% | -39.3% | |
| UHS | Universal Health Services, Inc.class b | $8,305,000 | -5.5% | 60,023 | 0.0% | 0.27% | -6.6% | |
| MPW | Medical Properties Trust, Inc. | $8,264,000 | -0.1% | 411,743 | 0.0% | 0.27% | -1.1% | |
| BSX | Boston Scientific Corp. | $8,068,000 | +1.5% | 185,931 | 0.0% | 0.26% | +0.8% | |
| TPTX | Turning Point Therapeutics, Inc. | $7,927,000 | -14.9% | 119,324 | 0.0% | 0.26% | -15.8% | |
| NTLA | Intellia Therapeutics, Inc. | $7,805,000 | -17.1% | 58,180 | 0.0% | 0.25% | -18.0% | |
| QURE | Buy | uniQure N.V.shares | $7,587,000 | +9.0% | 237,008 | +4.9% | 0.24% | +8.0% |
| STRO | Sutro Biopharma, Inc. | $7,559,000 | +1.6% | 400,147 | 0.0% | 0.24% | +0.4% | |
| SBRA | Sabra Health Care REIT, Inc. | $7,517,000 | -19.1% | 510,660 | 0.0% | 0.24% | -19.9% | |
| SNY | Buy | Sanofisponsored adr | $7,388,000 | +72.0% | 153,254 | +87.9% | 0.24% | +70.0% |
| PHG | Buy | Koninklijke Philips N.V.ny reg shares | $7,323,000 | +158.9% | 164,790 | +189.5% | 0.24% | +156.5% |
| GRTX | Sell | Galera Therapeutics, Inc. | $7,277,000 | -28.9% | 898,374 | -13.8% | 0.23% | -29.7% |
| ARVN | Arvinas, Inc. | $7,067,000 | +6.7% | 85,997 | 0.0% | 0.23% | +6.0% | |
| ADUS | Buy | Addus HomeCare Corp. | $6,670,000 | +41.0% | 83,632 | +54.2% | 0.22% | +39.6% |
| APLS | Buy | Apellis Pharmaceuticals, Inc. | $6,454,000 | -33.0% | 195,820 | +28.4% | 0.21% | -33.5% |
| SNN | Buy | Smith & Nephew plcsponsored adr | $6,240,000 | +33.4% | 181,710 | +68.8% | 0.20% | +32.2% |
| A | Sell | Agilent Technologies, Inc. | $6,242,000 | -19.6% | 39,625 | -24.6% | 0.20% | -20.2% |
| TEVA | Teva Pharmaceutical Industries Ltd.sponsored adr | $5,919,000 | -1.6% | 607,651 | 0.0% | 0.19% | -2.1% | |
| PKI | Sell | PerkinElmer, Inc. | $5,796,000 | +1.2% | 33,444 | -9.8% | 0.19% | +0.5% |
| LTC | LTC Properties, Inc. | $5,777,000 | -17.4% | 182,293 | 0.0% | 0.19% | -18.1% | |
| FOLD | Sell | Amicus Therapeutics, Inc. | $5,608,000 | -6.4% | 587,277 | -5.5% | 0.18% | -7.2% |
| AUPH | Sell | Aurinia Pharmaceuticals Inc. | $5,595,000 | +8.5% | 252,821 | -36.5% | 0.18% | +7.1% |
| QGEN | New | Qiagen N.V.shares | $5,574,000 | – | 107,855 | +100.0% | 0.18% | – |
| ANTM | Sell | Anthem, Inc. | $5,459,000 | -86.7% | 14,644 | -86.4% | 0.18% | -86.8% |
| VECT | Buy | VectivBio Holding AGshares | $5,372,000 | +217.7% | 756,502 | +421.7% | 0.17% | +214.5% |
| TVTX | Travere Therapeutics, Inc. | $5,162,000 | +66.2% | 212,869 | 0.0% | 0.17% | +64.4% | |
| KURA | Kura Oncology, Inc. | $5,122,000 | -10.2% | 273,463 | 0.0% | 0.16% | -10.8% | |
| PEAK | Healthpeak Properties, Inc. | $5,035,000 | +0.6% | 150,392 | 0.0% | 0.16% | -0.6% | |
| ARNA | Sell | Arena Pharmaceuticals, Inc. | $4,980,000 | -62.8% | 83,629 | -57.4% | 0.16% | -63.2% |
| ALGN | Sell | Align Technology, Inc. | $4,963,000 | -18.2% | 7,459 | -24.8% | 0.16% | -18.8% |
| TBPH | Theravance Biopharma, Inc. | $4,857,000 | -49.0% | 656,296 | 0.0% | 0.16% | -49.7% | |
| RCM | R1 RCM Inc. | $4,454,000 | -1.0% | 202,351 | 0.0% | 0.14% | -2.1% | |
| FATE | Fate Therapeutics, Inc. | $4,311,000 | -31.7% | 72,727 | 0.0% | 0.14% | -32.2% | |
| VRNA | Verona Pharma plcsponsored adr | $4,120,000 | -16.2% | 751,905 | 0.0% | 0.13% | -16.9% | |
| ZLAB | Zai Lab Ltd.adr | $3,955,000 | -40.4% | 37,523 | 0.0% | 0.13% | -41.2% | |
| MREO | Buy | Mereo BioPharma Group plcads | $3,754,000 | +13.3% | 1,551,082 | +48.5% | 0.12% | +12.0% |
| RMD | Sell | ResMed Inc. | $3,740,000 | -89.0% | 14,189 | -89.7% | 0.12% | -89.1% |
| AFMD | Sell | Affimed N.V. | $3,622,000 | -53.1% | 586,038 | -35.5% | 0.12% | -53.4% |
| SRRK | Scholar Rock Holding Corp. | $3,594,000 | +14.3% | 108,833 | 0.0% | 0.12% | +13.7% | |
| MEDP | Medpace Holdings, Inc. | $3,572,000 | +7.2% | 18,871 | 0.0% | 0.12% | +6.5% | |
| VIR | Vir Biotechnology, Inc. | $3,543,000 | -8.0% | 81,400 | 0.0% | 0.11% | -8.8% | |
| New | Stevanato Group SpAshares | $3,490,000 | – | 137,872 | +100.0% | 0.11% | – | |
| FMTX | Forma Therapeutics Holdings, Inc.shares | $3,474,000 | -6.8% | 149,825 | 0.0% | 0.11% | -7.4% | |
| TAK | Takeda Pharmaceutical Company Ltd.sponsored ads | $3,442,000 | -2.7% | 210,146 | 0.0% | 0.11% | -3.5% | |
| STE | Sell | STERIS plcshares | $3,405,000 | -40.3% | 16,669 | -39.7% | 0.11% | -40.5% |
| ARQT | Arcutis Biotherapeutics, Inc. | $3,145,000 | -12.4% | 131,633 | 0.0% | 0.10% | -13.7% | |
| HR | Healthcare Realty Trust Inc. | $3,098,000 | -1.4% | 104,024 | 0.0% | 0.10% | -2.0% | |
| WST | New | West Pharmaceutical Services, Inc. | $2,649,000 | – | 6,240 | +100.0% | 0.08% | – |
| TECH | Sell | Bio-Techne Corp. | $2,617,000 | -23.5% | 5,400 | -28.9% | 0.08% | -24.3% |
| GMRE | Global Medical REIT Inc. | $2,571,000 | -0.4% | 174,897 | 0.0% | 0.08% | -1.2% | |
| XENE | Xenon Pharmaceuticals Inc. | $2,583,000 | -17.9% | 169,030 | 0.0% | 0.08% | -18.6% | |
| STOK | New | Stoke Therapeutics, Inc. | $2,525,000 | – | 99,263 | +100.0% | 0.08% | – |
| HLXA | Helix Acquisition Corp. | $2,468,000 | -4.5% | 250,000 | 0.0% | 0.08% | -6.0% | |
| PRGO | Perrigo Company plcshares | $2,424,000 | +3.2% | 51,224 | 0.0% | 0.08% | +2.6% | |
| HTA | Healthcare Trust of America, Inc. | $2,096,000 | +11.1% | 70,662 | 0.0% | 0.07% | +9.8% | |
| HOLX | Sell | Hologic, Inc. | $2,092,000 | -3.7% | 28,347 | -12.9% | 0.07% | -5.6% |
| TCRR | TCR2 Therapeutics Inc. | $2,007,000 | -48.1% | 235,808 | 0.0% | 0.06% | -48.4% | |
| MORF | New | Morphic Holding, Inc. | $1,984,000 | – | 35,025 | +100.0% | 0.06% | – |
| CDXS | New | Codexis, Inc. | $1,871,000 | – | 80,448 | +100.0% | 0.06% | – |
| KALV | KalVista Pharmaceuticals, Inc. | $1,745,000 | -27.2% | 100,000 | 0.0% | 0.06% | -28.2% | |
| New | TScan Therapeutics, Inc. | $1,668,000 | – | 200,000 | +100.0% | 0.05% | – | |
| ENDP | Sell | Endo International plcshares | $1,603,000 | -35.6% | 494,607 | -7.0% | 0.05% | -35.8% |
| PTGX | New | Protagonist Therapeutics, Inc. | $1,528,000 | – | 86,237 | +100.0% | 0.05% | – |
| BCEL | Sell | Atreca, Inc. | $1,429,000 | -52.4% | 229,372 | -34.9% | 0.05% | -53.1% |
| PRAX | Praxis Precision Medicines, Inc. | $1,387,000 | +1.2% | 75,000 | 0.0% | 0.04% | 0.0% | |
| ZGNX | Zogenix, Inc. | $1,352,000 | -12.1% | 88,977 | 0.0% | 0.04% | -12.0% | |
| CCXI | ChemoCentryx, Inc. | $1,337,000 | +27.7% | 78,197 | 0.0% | 0.04% | +26.5% | |
| FULC | New | Fulcrum Therapeutics, Inc. | $1,238,000 | – | 43,898 | +100.0% | 0.04% | – |
| DHC | Diversified Healthcare Trust | $1,213,000 | -18.9% | 357,720 | 0.0% | 0.04% | -20.4% | |
| CYH | Community Health Systems, Inc. | $1,188,000 | -24.2% | 101,535 | 0.0% | 0.04% | -25.5% | |
| ITOS | New | iTeos Therapeutics, Inc. | $1,144,000 | – | 42,362 | +100.0% | 0.04% | – |
| BDTX | Black Diamond Therapeutics, Inc. | $1,117,000 | -30.6% | 131,990 | 0.0% | 0.04% | -30.8% | |
| MOR | MorphoSys AGsponsored ads | $963,000 | -38.9% | 81,867 | 0.0% | 0.03% | -39.2% | |
| BOLT | New | Bolt Biotherapeutics, Inc. | $823,000 | – | 65,025 | +100.0% | 0.03% | – |
| NKTX | Nkarta, Inc. | $806,000 | -12.3% | 28,988 | 0.0% | 0.03% | -13.3% | |
| ICPT | Sell | Intercept Pharmaceuticals, Inc. | $773,000 | -49.8% | 52,067 | -32.4% | 0.02% | -50.0% |
| DTIL | Precision BioSciences, Inc. | $727,000 | -7.9% | 63,001 | 0.0% | 0.02% | -11.5% | |
| ARDX | Ardelyx, Inc. | $712,000 | -82.6% | 539,408 | 0.0% | 0.02% | -82.7% | |
| CHCT | Community Healthcare Trust Inc. | $673,000 | -4.8% | 14,900 | 0.0% | 0.02% | -4.3% | |
| ONEM | 1Life Healthcare, Inc. | $633,000 | -38.8% | 31,266 | 0.0% | 0.02% | -41.2% | |
| UHT | Universal Health Realty Income Trustshares | $622,000 | -10.2% | 11,258 | 0.0% | 0.02% | -13.0% | |
| ALXO | New | ALX Oncology Holdings Inc. | $524,000 | – | 7,099 | +100.0% | 0.02% | – |
| NHI | National Health Investors, Inc. | $537,000 | -20.2% | 10,038 | 0.0% | 0.02% | -22.7% | |
| GMDA | Gamida Cell Ltd.shares | $463,000 | -38.8% | 118,142 | 0.0% | 0.02% | -40.0% | |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $422,000 | -44.3% | 413,481 | 0.0% | 0.01% | -44.0% | |
| ASRT | Assertio Holdings, Inc. | $372,000 | -41.9% | 410,575 | 0.0% | 0.01% | -42.9% | |
| FUSN | New | Fusion Pharmaceuticals Inc. | $344,000 | – | 43,394 | +100.0% | 0.01% | – |
| SPPI | Spectrum Pharmaceuticals, Inc. | $250,000 | -41.9% | 114,670 | 0.0% | 0.01% | -42.9% | |
| VYNE | VYNE Therapeutics Inc. | $188,000 | -60.4% | 135,395 | 0.0% | 0.01% | -60.0% | |
| OGN | Sell | Organon & Co. | $122,000 | -92.6% | 3,717 | -93.1% | 0.00% | -92.5% |
| FVE | Five Star Senior Living Inc. | $106,000 | -24.3% | 24,237 | 0.0% | 0.00% | -40.0% | |
| ABIO | ARCA biopharma, Inc. | $96,000 | -15.0% | 32,461 | 0.0% | 0.00% | -25.0% | |
| Bellicum Pharmaceuticals, Inc. | $18,000 | -10.0% | 6,000 | 0.0% | 0.00% | 0.0% | ||
| Exit | Tetraphase Pharmaceuticals, Inc. | $0 | – | -42,965 | -100.0% | 0.00% | – | |
| CLDX | Exit | Celldex Therapeutics, Inc. | $0 | – | -7,053 | -100.0% | -0.01% | – |
| CBAY | Exit | CymaBay Therapeutics, Inc. | $0 | – | -88,102 | -100.0% | -0.01% | – |
| RGNX | Exit | REGENXBIO Inc. | $0 | – | -21,700 | -100.0% | -0.03% | – |
| GRFS | Exit | Grifols, S.A.sponsored adr | $0 | – | -47,373 | -100.0% | -0.03% | – |
| EDIT | Exit | Editas Medicine, Inc. | $0 | – | -15,190 | -100.0% | -0.03% | – |
| TFX | Exit | Teleflex Inc. | $0 | – | -2,200 | -100.0% | -0.03% | – |
| MDGL | Exit | Madrigal Pharmaceuticals, Inc. | $0 | – | -13,340 | -100.0% | -0.04% | – |
| OVID | Exit | Ovid Therapeutics Inc.sponsored adr | $0 | – | -372,733 | -100.0% | -0.05% | – |
| MTEM | Exit | Molecular Templates, Inc. | $0 | – | -199,420 | -100.0% | -0.05% | – |
| SNR | Exit | New Senior Investment Group Inc. | $0 | – | -256,398 | -100.0% | -0.07% | – |
| DRNA | Exit | Dicerna Pharmaceuticals, Inc. | $0 | – | -68,150 | -100.0% | -0.08% | – |
| JNCE | Exit | Jounce Therapeutics, Inc. | $0 | – | -382,237 | -100.0% | -0.08% | – |
| INSM | Exit | Insmed Inc. | $0 | – | -98,387 | -100.0% | -0.09% | – |
| NKTR | Exit | Nektar Therapeutics | $0 | – | -180,438 | -100.0% | -0.10% | – |
| PRAH | Exit | PRA Health Sciences, Inc. | $0 | – | -25,068 | -100.0% | -0.14% | – |
| COGT | Exit | Cogent Biosciences, Inc. | $0 | – | -537,742 | -100.0% | -0.14% | – |
| PSNL | Exit | Personalis, Inc. | $0 | – | -179,731 | -100.0% | -0.15% | – |
| CNC | Exit | Centene Corp. | $0 | – | -67,290 | -100.0% | -0.16% | – |
| Exit | Trillium Therapeutics Inc. | $0 | – | -529,226 | -100.0% | -0.17% | – | |
| RETA | Exit | Reata Pharmaceuticals, Inc.class a | $0 | – | -38,219 | -100.0% | -0.18% | – |
| SAGE | Exit | Sage Therapeutics, Inc. | $0 | – | -114,119 | -100.0% | -0.21% | – |
| YMAB | Exit | Y-mAbs Therapeutics, Inc. | $0 | – | -197,820 | -100.0% | -0.22% | – |
| ACAD | Exit | ACADIA Pharmaceuticals Inc. | $0 | – | -331,789 | -100.0% | -0.26% | – |
| REPL | Exit | Replimune Group, Inc. | $0 | – | -219,060 | -100.0% | -0.27% | – |
| INCY | Exit | Incyte Corp. | $0 | – | -107,687 | -100.0% | -0.29% | – |
| EXEL | Exit | Exelixis, Inc. | $0 | – | -499,657 | -100.0% | -0.30% | – |
| BPMC | Exit | Blueprint Medicines Corp. | $0 | – | -122,699 | -100.0% | -0.35% | – |
| DCPH | Exit | Deciphera Pharmaceuticals, Inc. | $0 | – | -307,703 | -100.0% | -0.37% | – |
| ALLK | Exit | Allakos Inc. | $0 | – | -133,045 | -100.0% | -0.37% | – |
| BBIO | Exit | BridgeBio Pharma, Inc. | $0 | – | -188,767 | -100.0% | -0.37% | – |
| AMED | Exit | Amedisys, Inc. | $0 | – | -48,070 | -100.0% | -0.38% | – |
| ALXN | Exit | Alexion Pharmaceuticals, Inc. | $0 | – | -64,453 | -100.0% | -0.38% | – |
| IOVA | Exit | Iovance Biotherapeutics, Inc. | $0 | – | -468,538 | -100.0% | -0.40% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Gilead Sciences, Inc. | 41 | Q2 2023 | 12.4% |
| Amgen, Inc. | 41 | Q2 2023 | 5.8% |
| Biogen Inc. | 41 | Q2 2023 | 6.5% |
| Vertex Pharmaceuticals Incorporated | 41 | Q2 2023 | 5.3% |
| Regeneron Pharmaceuticals, Inc. | 41 | Q2 2023 | 9.1% |
| Illumina, Inc. | 41 | Q2 2023 | 3.4% |
| BioMarin Pharmaceutical Inc. | 41 | Q2 2023 | 2.9% |
| Teva Pharmaceutical Industries Ltd. | 41 | Q2 2023 | 3.2% |
| Neurocrine Biosciences, Inc. | 41 | Q2 2023 | 1.4% |
| McKesson Corporation | 41 | Q2 2023 | 2.2% |
View Tekla Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Rallybio Corp | January 23, 2023 | 1,727,067 | 4.6% |
| Zyla Life SciencesSold out | January 29, 2021 | 0 | 0.0% |
| ARCA biopharma, Inc. | January 24, 2020 | 36,068 | 2.3% |
| Verona Pharma plc | February 12, 2019 | 5,296,845 | 4.9% |
| Alliqua BioMedical, Inc. | February 12, 2018 | 165,000 | 3.3% |
| PIERIS PHARMACEUTICALS, INC. | February 12, 2018 | 1,962,380 | 4.4% |
| Intellipharmaceutics International Inc. | February 13, 2015 | 2,184,000 | 9.0% |
| HERON THERAPEUTICS, INC. /DE/ | February 14, 2014 | 20,598,613 | 4.2% |
| MEDWAVE INC | February 14, 2012 | 1,277,372 | 9.8% |
| MZT Holdings, Inc. | February 14, 2012 | 2,553,420 | 4.0% |
View Tekla Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-02-10 |
| SC 13G/A | 2023-01-23 |
| 13F-HR | 2022-11-01 |
| 13F-HR | 2022-07-29 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| SC 13G | 2022-01-21 |
| 13F-HR | 2021-11-12 |
View Tekla Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.